Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62021TN0601

    Case T-601/21: Action brought on 20 September 2021 — Pharmadom v EUIPO — Wellstat Therapeutics (WELLMONDE)

    IO C 481, 29.11.2021, p. 33–34 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    29.11.2021   

    EN

    Official Journal of the European Union

    C 481/33


    Action brought on 20 September 2021 — Pharmadom v EUIPO — Wellstat Therapeutics (WELLMONDE)

    (Case T-601/21)

    (2021/C 481/47)

    Language of the case: English

    Parties

    Applicant: Pharmadom (Boulogne-Billancourt, France) (represented by: M.-P. Dauquaire, lawyer)

    Defendant: European Union Intellectual Property Office (EUIPO)

    Other party to the proceedings before the Board of Appeal: Wellstat Therapeutics Corp. (Rockville, Maryland, United States)

    Details of the proceedings before EUIPO

    Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal

    Trade mark at issue: Application for European Union word mark WELLMONDE — Application for registration No 16 152 803

    Procedure before EUIPO: Opposition proceedings

    Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 23 June 2021 in Case R 1776/2020-5

    Form of order sought

    The applicant claims that the Court should:

    annul the contested decision;

    Plea in law

    Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.


    Top